# PEMETREXED DISODIUM
> **ANDA202111** · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2022-05-25
## Drug
- **FDA Application Number:** ANDA202111
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PEMETREXED DISODIUM
- **Generic name:** MEXILETINE HYDROCHLORIDE
- **Active ingredients:** PEMETREXED DISODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** HOSPIRA
- **Manufacturer:** Senores Pharmaceuticals, Inc.
- **First approval:** 2022-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202111)
---
*AI Analytics · CC0 1.0*